Category: biotech

.Charles Baum, M.D., Ph.D., who oversaw Mirati Therapies’ $ 5.8 billion sale to Bristol Myers Squibb in 2013, is actually taking the controls of young

.China-based Minghui Pharmaceutical has linked its thyroid eye condition procedure to a decrease in eye bulging in a small stage 1b/2 clinical test.The research enlisted

.Welcome to this week’s Chutes &amp Ladders, our roundup of considerable management hirings, firings as well as retirings all over the industry. Feel free to

.It is actually difficult to muscular tissue in on an area as competitive as immunology, yet Celldex Rehabs strongly believes that its own most current

.Gritstone biography has produced lenders to look into “possible value-maximizing techniques” after its own period 2 colorectal cancer vaccination records disappointed the loose results required

.Cassava Sciences has actually agreed to spend $40 thousand to deal with an inspection in to claims it made deceiving declarations about stage 2b information

.Having already scooped up the USA liberties to Capricor Rehabs’ late-stage Duchenne muscular dystrophy (DMD) treatment, Asia’s Nippon Shinyaku has actually approved $35 thousand in

.Capricor Therapies is actually taking a success tour for their phase 2 Duchenne muscle dystrophy (DMD) trial. At 3 years, the San Diego-based provider’s tissue

.BridgeBio Pharma is actually slashing its gene therapy budget and drawing back from the method after seeing the end results of a period 1/2 professional

.RNA biotech CAMP4 Therapies has marked out plans for a $67 thousand IPO, with inflammation-focused Upstream Biography fixing its very own dreams at $182 thousand.While